Atlas Trials

Qi Zhou

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Qi Zhou

RecordFirmDate
A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer (NCT07266350)Qi Zhou2025-12-30
A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH ) (NCT04998760)Qi Zhou2021-08-03
Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa (NCT03944239)Qi Zhou2021-05-19
Clinical Safety Study of Human Embryonic Stem Cell Derived Mesenchymal Cells in the Treatment of Moderate and Severe Intrauterine Adhesions (NCT04232592)Qi Zhou2020-01-01

Track Qi Zhou automatically

Every clearance here is in the API, with alerts when new ones post.